Investor
Relations

Financial Information

Quarterly Results
Financial Highlights
Annual Report
Financial Calendar
Quarterly Report For The Financial Period Ended 30 June 2025

Download PDF
Financials Archive

View More

Notes:

(a) The unaudited condensed Consolidated Statement of Financial Position should be read in conjunction with the audited financial statements for the financial year ended 30 September 2024 and the accompanying explanatory notes attached to this interim financial report.

(b) Based on 671,682,446 ordinary shares in issue as disclosed in Note B11.

Notes:

(a) The Unaudited Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income should be read in conjunction with the audited financial statements for the financial year ended 30 September 2024 and the accompanying explanatory notes attached to this interim financial report.

(b) Based on 671,682,446 ordinary shares in issue as disclosed in Note B11.

(c) Diluted earnings per share for the current financial period is calculated by dividing the profit for the financial period attributable to owners of the Company by the weighted average number of ordinary shares outstanding during the financial period adjusted for the effects of dilutive potential ordinary shares as disclosed in Note B11.

Comparison with the preceding year corresponding quarter

The Group consolidate the wholly owned subsidiary, TMSS book effective previous quarter ("Q2FY25").

The Group's revenue recorded an increase of 84% in the current quarter ("Q3FY25") as compared to the preceding year corresponding quarter ("Q3FY24") due to the higher demand from various market segments especially market segment of the CMOS Image sensor market.

Operating expenses increased primarily due to the consolidation of TMSS's expenses.

Profit before tax improving mainly attributed to higher revenue recorded and cost control efforts.

In Q3FY25, we experienced delays in orders in China sales region. The orders are expected to realise in the next few quarters. On the other hand, with the latest transfer of CIS business from Revotronix as announced on even date, the revenue contribution from CIS market segment is expected to enhance our financial performance.

We foresee large contributions of revenue from the ROW sales region for the automotive market segment in the Q4FY25. Orders have been obtained and the tester manufacturing is work-in-progress.

China sales region may take a breather in Q4FY25 due to the longer order processing and manufacturing processes. However, we are excited over the transfer of CIS business. Together with the acquisition of 60% shares of our former joint-venture, TMSS, we look forward to better financial contribution in the coming quarters.